| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b585d62c6065b4b93a22de577f7bf031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c30ae135cc58afacbf5ecec1322dc1f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1806 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06 |
| filingDate |
2010-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77e52ee6f6d33296510a5642e7a2e96b |
| publicationDate |
2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011003818-A2 |
| titleOfInvention |
Diagnostic method |
| abstract |
Diagnostic methods for determining whether a subject suffers from hepatic fibrosis, comprising the following steps: a) providing a contrast agent comprising a manganese (II) compound; b) administering the contrast agent orally to the subject; and c) subjecting the subject to magnetic resonance imaging of the liver after administration of the contrast agent. |
| priorityDate |
2009-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |